Company news

Royalty Pharma plc news in 2020

Royalty Pharma plc's news releases, calls and decks from 2020, newest first.

View company

Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities

December 21, 2020

Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals

December 6, 2020

Royalty Pharma Reports Third Quarter 2020 Results

November 9, 2020

Royalty Pharma Acquires Additional Royalty Interest From the Cystic Fibrosis Foundation

November 1, 2020

Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders

October 19, 2020

Royalty Pharma to Announce Third-Quarter 2020 Financial Results on November 11, 2020

October 18, 2020

Royalty Pharma Declares Fourth-Quarter 2020 Dividend

October 14, 2020

Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders

October 12, 2020

Royalty Pharma Declares Third-Quarter 2020 Dividend

September 1, 2020

Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes

September 1, 2020

Royalty Pharma Announces Pricing of $6.0 Billion Senior Unsecured Notes

August 24, 2020

Royalty Pharma Announces Launch of Senior Notes Offering

August 18, 2020

Royalty Pharma Reports Second Quarter 2020 Results

August 11, 2020

Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million

August 6, 2020

Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

August 2, 2020

Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12

July 19, 2020

Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics

July 19, 2020

Decks in 2020